The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
Open Access
- 14 May 1998
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 338 (20), 1405-1412
- https://doi.org/10.1056/nejm199805143382002
Abstract
Influenzavirus vaccine is used infrequently in healthy children, even though the rates of influenza in this group are high. We conducted a multicenter, double-blind, placebo-controlled trial of a live attenuated, cold-adapted, trivalent influenzavirus vaccine in children 15 to 71 months old.Keywords
This publication has 18 references indexed in Scilit:
- Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and EfficacyThe Journal of Infectious Diseases, 1996
- Human immune responses to influenza virus vaccines administered by systemic or mucosal routesVaccine, 1995
- Mucosal Vaccines for the Prevention of InfluenzaDrugs, 1995
- Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type BJAMA, 1994
- Virus and Bacteria Enhance Histamine Production in Middle Ear Fluids of Children with Acute Otitis MediaThe Journal of Infectious Diseases, 1994
- Multidose, Live Attenuated, Cold-Recombinant, Trivalent Influenza Vaccine in Infants and Young ChildrenThe Journal of Infectious Diseases, 1994
- Effect of viral respiratory tract infection on outcome of acute otitis mediaThe Journal of Pediatrics, 1992
- Respiratory Viruses Interfere with Bacteriologic Response to Antibiotic in Children with Acute Otitis MediaThe Journal of Infectious Diseases, 1990
- Evaluation of a Cold-Recombinant Influenza Virus Vaccine in FerretsThe Journal of Infectious Diseases, 1982
- Influenza in children. Relationship to other respiratory agentsJAMA, 1980